9 September 2022 - People with rare cancers are being forced to sell their homes, raid their superannuation and fundraise as much as $10,000 a month to pay for immunotherapy drugs as the number of patients unable to access innovative cancer technologies, therapies and services grows larger.

Publicly funded immunotherapy treatments are now available for a host of common cancers and are saving and extending cancer patients’ lives, often when other treatments have failed.

Read The Australian article